Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin Flexpro, is a growth hormone presented as a solution for injection for subcutaneous use. It treats growth hormone deficiency in children and adults, Turner syndrome, chronic renal failure, and Prader‑Willi syndrome.

GNH USA supplies Norditropin Flexpro as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Norditropin Flexpro (somatropin) is used in conditions related to growth hormone deficiency and associated growth disorders.

- Growth hormone deficiency in children: promotes linear growth and improves height velocity. - Growth hormone deficiency in adults: enhances body composition, reduces fat mass, and improves quality of life. - Turner syndrome: supports growth and development of stature in affected females. - Chronic renal failure: aids growth in pediatric patients with renal insufficiency. - Prader‑Willi syndrome: helps increase height and improve body composition.

Common side effects are generally mild and related to the injection process or transient metabolic changes.

Common Side Effects: - Injection site pain or erythema - Headache - Joint or muscle pain - Peripheral edema - Nausea - Fatigue

Serious or Rare Side Effects: - Intracranial hypertension - Slipped capital femoral epiphysis - Glucose intolerance or new‑onset diabetes - Severe allergic reactions (anaphylaxis) - Tumor recurrence or progression - Cardiomyopathy

Before initiating therapy, clinicians should assess baseline parameters and monitor patients regularly.

- Monitor IGF‑1 levels: adjust dose to maintain target range. - Screen for malignancy: avoid use in active cancer patients. - Adjust dose in renal or hepatic impairment: consider reduced dosing. - Use caution in patients with diabetes: monitor glucose control. - Observe for signs of intracranial hypertension: report headaches or visual changes. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Somatropin may interact with several drug classes, requiring clinical awareness.

Major Interactions (Avoid): - Concurrent use of other growth hormone products: risk of overdose. - High‑dose glucocorticoids: may diminish somatropin efficacy. - Estrogen therapy: can reduce IGF‑1 response.

Moderate Interactions (Monitor Closely): - Antidiabetic medications: GH may increase blood glucose, requiring dose adjustment. - Thyroid hormone replacement: GH can increase thyroid hormone requirements. - Loop diuretics: may enhance fluid retention.